Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 50 history starts 18 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | LIC MF Nifty 50 Index Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹103.00 |
| 12 Apr 2015 | ₹147.26 |
| 31 May 2016 | ₹137.80 |
| 19 Jul 2017 | ₹167.81 |
| 07 Sep 2018 | ₹196.32 |
| 27 Oct 2019 | ₹198.27 |
| 15 Dec 2020 | ₹232.88 |
| 03 Feb 2022 | ₹302.93 |
| 25 Mar 2023 | ₹295.57 |
| 12 May 2024 | ₹387.91 |
| 01 Jul 2025 | ₹454.73 |
| 20 Aug 2026 | ₹434.47 |
| Metric | LIC · Direct · IDCW NAV ₹53.52 Very High risk ★★★☆☆ | Category median Index Funds · 271 funds |
|---|---|---|
| -2.85% | +5.06% | |
| +8.64% | +7.78% | |
| +8.94% | +8.94% | |
| +11.46% | +10.39% | |
| +11.38% | +7.54% | |
| +7.23% | — | |
| +12.54% | +8.12% | |
| +12.82% | +12.83% | |
| +12.56% | +11.97% | |
| Risk | ||
| 13.18% | 13.54% | |
| 0.16 | 0.16 | |
| 0.23 | 0.22 | |
| -38.11% | -15.77% | |
| Nifty 50 | — | |
| +0.75% | +0.53% | |
| 1.00 | 1.00 | |
| 101.6% | 102.2% | |
| 97.1% | 98.0% | |
| 0.56% | 0.34% | |
| ₹358.29Cr | ₹191.88Cr | |
| 0.25% | — | |
| None | — | |
| ₹200 | — | |
| ₹5.00K | — | |
| 31% | 38% | |
| Sumit Bhatnagar · 2.9y | — | |
| 02 Jan 2013 | — | |
| 50 | — | |
| 53.6% | — | |
| 0.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.